Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 2522-2528, June 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trikha, M.
Right arrow Articles by Honn, K. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trikha, M.
Right arrow Articles by Honn, K. V.

The High Affinity {alpha}IIbß3 Integrin Is Involved in Invasion of Human Melanoma Cells1

Mohit Trikha, Jozsef Timar, Steven K. Lundy, Karoly Szekeres, Yinlong Cai, Arthur T. Porter and Kenneth V. Honn2

Departments of Radiation Oncology [M. T., S. K. L., K. S., Y. C., A. T. P., K. V. H.] and Pathology and Chemistry [K. V. H.], Wayne State University, and Barbara Ann Karmanos Cancer Center, The Detroit Medical Center [K. V. H.], Detroit, Michigan 48202, and First Institute of Pathology and Experimental Cancer Research, Semmelweis University of Medicine, Budapest, H-1085, Hungary [J. T.]

Integrins play an important role in mediating tumor cell-extracellular matrix (ECM) and tumor cell-endothelial cell interactions. The integrin {alpha}IIbß3 (GPIIb-IIIa) is expressed on the surface of platelets in an inactive state and requires a conformational change to recognize extracellular matrix proteins such as fibrinogen, fibronectin, vitronectin, and others. In this study, we questioned whether human melanoma cells express the {alpha}IIbß3 integrin. Reverse transcription-PCR/Southern blotting, Northern blotting, and dot blotting demonstrated the presence of the platelet-type {alpha}IIbß3 integrin in human melanoma WM 983B, WM 983A, and WM 35 cells. AP-2, a monoclonal antibody (mAb) to {alpha}IIbß3, positively stained two human melanoma specimens, indicating expression of this integrin in vivo. Phorbol 12-myristate 13-acetate and 12(S)-hydroxyeicosatetraenoic acid, two activators of protein kinase C, stimulated adhesion of melanoma cells to immobilized fibronectin and PAC-1, a mAb to {alpha}IIbß3. PAC-1 specifically recognizes the conformationally active form of platelet {alpha}IIbß3. Phorbol 12-myristate 13-acetate-stimulated adhesion of WM 983B cells to PAC-1 was completely blocked by an RGD peptide, thus providing evidence that tumor cell adhesion to PAC-1 is mediated via the {alpha}IIbß3 integrin but not the Fc receptor. Confocal immunofluorescent studies demonstrated that fibronectin-adherent melanoma cells possess an intracellularly localized pool of high-affinity {alpha}IIbß3. Invasion of WM 983B cells through fibronectin was stimulated by 12(S)-hydroxyeicosatetraenoic acid, and this stimulated invasion was blocked by the mAb PAC-1. The data suggest that melanoma cells express the high-affinity {alpha}IIbß3 integrin, which is involved in tumor invasion.

1 This work was supported by NIH Department of Health and Human Services Grants CA-47115-08 (to K. V. H.), CA-29997-14 (to K. V. H.), Harper Developmental Fund (to K. V. H.) TW-285-03 (to K. V. H. and J. T.), NATO CRG950287 (to K. V. H. and J. T.), Hungarian Ministry of Welfare 343/93 (to J. T.), the Hungarian National Science Fund T21149 (J. T.), and a National Cancer Institute fellowship (to M. T.).

2 To whom requests for reprints should be addressed, at Wayne State University, 431 Chemistry Building, Detroit, MI 48202. Phone: (313) 577-1018; Fax (313) 577-0798.

Received 10/30/96. Accepted 4/15/97.




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Trikha, Z. Zhou, J. Timar, E. Raso, M. Kennel, E. Emmell, and M. T. Nakada
Multiple Roles for Platelet GPIIb/IIIa and {alpha}v{beta}3 Integrins in Tumor Growth, Angiogenesis, and Metastasis
Cancer Res., May 1, 2002; 62(10): 2824 - 2833.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
J. R. Chan, S. J. Hyduk, and M. I. Cybulsky
Chemoattractants Induce a Rapid and Transient Upregulation of Monocyte {alpha}4 Integrin Affinity for Vascular Cell Adhesion Molecule 1 Which Mediates Arrest: An Early Step in the Process of Emigration
J. Exp. Med., May 14, 2001; 193(10): 1149 - 1158.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. M. Smorenburg and C. J. F. Van Noorden
The Complex Effects of Heparins on Cancer Progression and Metastasis in Experimental Studies
Pharmacol. Rev., March 1, 2001; 53(1): 93 - 106.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. L. Vassilev, M. D. Kazatchkine, J.-P. D. Van Huyen, M. Mekrache, E. Bonnin, J. C. Mani, C. Lecroubier, D. Korinth, D. Baruch, F. Schriever, et al.
Inhibition of Cell Adhesion by Antibodies to Arg-Gly-Asp (RGD) in Normal Immunoglobulin for Therapeutic Use (Intravenous Immunoglobulin, IVIg)
Blood, June 1, 1999; 93(11): 3624 - 3631.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Lochter, M. Navre, Z. Werb, and M. J. Bissell
alpha 1 and alpha 2 Integrins Mediate Invasive Activity of Mouse Mammary Carcinoma Cells through Regulation of Stromelysin-1 Expression
Mol. Biol. Cell, February 1, 1999; 10(2): 271 - 282.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.